Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable artesunate for severe malaria
jRCTs031240737Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of artesunate in malaria, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: In-hospital mortality rate. Started Dec 2025; status: recruiting.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on jRCTs031240737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240737.